To ascertain that elevated levels of NCAPH were associated with a diminished response to chemotherapy, we engineered an MCF7 luminal A breast cancer cell line wherein NCAPH overexpression could be triggered by doxycycline (Figure 2H,I). The gene discussed is NCAPH; the disease is breast carcinoma.